What does "AI visibility" mean for my business?

When someone asks ChatGPT, Claude, or Gemini "what is the best..." or "where can I find...", AI gives specific recommendations. AI visibility is a measure of how often — and how positively — these AI platforms mention your business. It's the new version of being on the first page of Google, except now there are no pages — just one answer.

Which AI platforms do you monitor?

Pendium monitors ChatGPT, Claude, Gemini, Grok, Perplexity, DeepSeek, and Google AI Overviews — seven major AI platforms that consumers use to research local services. We run real queries that your customers actually ask and analyze the responses for mentions of your business, competitors, and industry topics.

How does Pendium improve my visibility?

Three ways. First, we identify the exact queries and topics where you're invisible. Second, we generate AI-optimized content — articles, guides, social posts — designed to help AI agents understand your business and recommend your services to the right people. Third, we continuously monitor to track improvement and find new opportunities. Most clients see measurable improvement within 60 days.

How long until I see results?

You'll get your first visibility report within minutes of signing up. Actual visibility improvement varies, but our clients typically see a 47% average improvement within 60 days. Some see results faster — it depends on your current online presence and how competitive your local market is.

Do I need to be technical to use this?

Not at all. Enter your website URL and Pendium handles everything: scanning AI platforms, analyzing your visibility, generating content, and tracking improvement. The dashboard is designed for business owners, not engineers. If you can check your email, you can use Pendium.

What makes this different from SEO?

Traditional SEO optimizes for Google's search rankings — blue links on a results page. AI visibility is different: AI doesn't show links, it gives direct answers. Even if you rank #1 on Google, ChatGPT might recommend a competitor. Pendium optimizes for the new paradigm — making sure AI platforms know about, trust, and recommend your business.

Roadmap Pricing

Get a demo

Bristol Myers Squibb

Visibility70

Vibe100

This is a preview of our capabilities. To see the full results across all LLMs, run a full scan.

Businesses/Healthcare / Pharmaceuticals/Bristol Myers Squibb

AI Visibility & Sentiment

Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical leader dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases. The company focuses on specialty therapeutic areas where there is a high unmet medical need, leveraging advanced science to transform the treatment of cancer, cardiovascular conditions, and autoimmune disorders.

Active Monitoring

bms.com

Healthcare / Pharmaceuticals

Partial scan

AI Visibility Score

70/100

Good

Sentiment Score

100/100

Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

adjacent

aspirational

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Bristol Myers Squibb today.

Bristol Myers Squibb is currently missing a critical opportunity to establish itself as an AI-driven authority, remaining largely absent from core clinical and treatment-related conversations where it should be a primary reference. While the brand maintains a notable presence in oncology-specific discussions, its failure to appear in essential clinical efficacy and medication management queries allows competitors to capture the trust of decision-makers by default.

Working in your favor

Secured a position in AI Overviews for high-level clinical innovation and trust queries.

Effective brand resonance within oncology-focused leadership discussions, maintaining a strong position in relevant search results.

Gaps to close

Total absence in high-intent queries regarding standard of care options for metastatic conditions.

Complete lack of visibility in anticoagulation and cardiovascular management, allowing smaller specialized players like Medisafe and MyTherapy to dominate.

Failure to provide authoritative content for Clinical Research Leads and Specialized Care Advocates, key personas for long-term clinical adoption.

Opportunities

Repurpose clinical trial and efficacy data into structured, AI-optimized content to win standard-of-care category queries.

Develop patient adherence and cardiovascular management content to challenge niche digital tool competitors in AI-driven search.

Target high-intent personas by addressing specific evidence-based questions about biologic treatments and CAR-T therapies.

Highest-Impact Actions

Develop a structured knowledge graph of clinical efficacy data for core therapeutic areas.

AI models prioritize structured, verifiable clinical data when answering 'standard of care' queries, which is the biggest area of current invisibility.

Produce content specifically addressing the evidence-based advantages of Bristol Myers Squibb’s anticoagulants.

Currently, search results for these products are being captured by peripheral apps rather than the pharmaceutical leader, representing a significant loss of brand authority.

Publish white papers and thought leadership targeting the 'Clinical Research Lead' and 'Specialized Care Advocate' personas.

These personas are currently receiving zero engagement from the brand, creating an open lane for competitors to establish early influence in clinical decision-making.

Value Proposition

BMS delivers 'Innovation that Transforms Lives' by providing profound clinical benefit in high-acuity specialty areas and offering therapeutic options for diseases with previously limited treatment paths.

Overview

Mission

To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Products & Services

Eliquis (apixaban)Opdivo (nivolumab)Orencia (abatacept)Revlimid (lenalidomide)Breyanzi & Abecma (CAR-T cell therapies)

Current State

Visibility Landscape

A high-level view of how Bristol Myers Squibb performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

	ChatGPT	Claude	Gemini	AI Overviews
Reputation1q Sentiment when asked about the brand directly	—	—	—	—
“What do you know about Bristol Myers Squibb? What do they do and what's their reputation?”	—	—	—	—
Core4q Product/service category queries	—	—	—	—
“what are the current standard of care options for metastatic melanoma that show the best long-term survival rates”	—	—	—	—
“what are the leading direct oral anticoagulants to consider for stroke prevention in patients with non-valvular atrial fibrillation”	—	—	—	—
“compare the efficacy of different CAR-T cell therapies currently available for large B-cell lymphoma”	—	—	—	—
“which blood thinners have the most robust clinical evidence for reducing bleeding risks in geriatric patients”	—	—	—	—
Growth Areas4q Adjacent, aspirational & visionary	—	—	—	44
“what are the most reputable pharmaceutical companies known for developing innovative immunology and oncology drugs”	—	—	—	—
“what are the most effective biologic treatments for moderate-to-severe rheumatoid arthritis besides traditional dmards”	—	—	—	—
“best digital tools for tracking patient adherence to long-term medication regimens for heart disease”	—	—	—	—
“what should patients look for when evaluating the safety and research backing of new immunotherapy treatments”	—	—	—	No

“What do you know about Bristol Myers Squibb? What do they do and what's their reputation?”

—

“what are the current standard of care options for metastatic melanoma that show the best long-term survival rates”

—

“what are the leading direct oral anticoagulants to consider for stroke prevention in patients with non-valvular atrial fibrillation”

—

“compare the efficacy of different CAR-T cell therapies currently available for large B-cell lymphoma”

—

“which blood thinners have the most robust clinical evidence for reducing bleeding risks in geriatric patients”

—

“what are the most reputable pharmaceutical companies known for developing innovative immunology and oncology drugs”

—

“what are the most effective biologic treatments for moderate-to-severe rheumatoid arthritis besides traditional dmards”

—

“best digital tools for tracking patient adherence to long-term medication regimens for heart disease”

—

“what should patients look for when evaluating the safety and research backing of new immunotherapy treatments”

—

Brand Ecosystem

Medisafe

1 mention

MyTherapy

1 mention

American Heart Association (HF Helper)

1 mention

EveryDose

1 mention

AdhereTech

adheretech.com

1 mention

Pillsy

1 mention

Tenovi Pillbox

1 mention

Proteus

1 mention

HeartGuardian

1 mention

Roche (Genentech, Tecentriq, Herceptin, Avastin)

1 mention

Bristol Myers Squibb

1 mention

Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Bristol Myers Squibb's AI visibility.

Key Findings

Strength

Secured a position in AI Overviews for high-level clinical innovation and trust queries.

Strength

Effective brand resonance within oncology-focused leadership discussions, maintaining a strong position in relevant search results.

Gap

Total absence in high-intent queries regarding standard of care options for metastatic conditions.

Recommended Actions

Develop a structured knowledge graph of clinical efficacy data for core therapeutic areas.

AI models prioritize structured, verifiable clinical data when answering 'standard of care' queries, which is the biggest area of current invisibility.

Produce content specifically addressing the evidence-based advantages of Bristol Myers Squibb’s anticoagulants.

Currently, search results for these products are being captured by peripheral apps rather than the pharmaceutical leader, representing a significant loss of brand authority.

Publish white papers and thought leadership targeting the 'Clinical Research Lead' and 'Specialized Care Advocate' personas.

These personas are currently receiving zero engagement from the brand, creating an open lane for competitors to establish early influence in clinical decision-making.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

Therapeutic Area Efficacy And Comparison(3 queries)

“what are the current standard of care options for metastatic melanoma that show the best long-term survival rates”

0/0 platforms mentioned

Core

“compare the efficacy of different CAR-T cell therapies currently available for large B-cell lymphoma”

0/0 platforms mentioned

Core

Clinical Research Lead · Lead Researcher

“what are the most effective biologic treatments for moderate-to-severe rheumatoid arthritis besides traditional dmards”

0/0 platforms mentioned

Adjacent

Clinical Research Lead · Lead Researcher

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

Technologies for Medication Adherence Monitoring and ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Key Features of Smart Medication Adherence Products - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Artificial Intelligence Solutions to Increase Medication ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

AdhereTech: Medication Adherence Solutions for Better Health

adheretech.com

Bristol Myers Squibb

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Sample Conversations

Citations

Engineer content that makes AI agents recommend you

Explore Healthcare / Pharmaceuticals

Start gettingrecommended by AI.

Frequently asked questions

Bristol Myers Squibb

Key Takeaways

Visibility Landscape

Insights & Recommended Actions

Sample Conversations

Citations

Engineer content that makes AI agents recommend you

Explore Healthcare / Pharmaceuticals

Start gettingrecommended by AI.

Frequently asked questions

Start getting
recommended by AI.

Start getting
recommended by AI.